We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.
CITATION STYLE
Hui, Z., Zhang, X., Ren, B., Li, R., & Ren, X. (2015). Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells. Frontiers in Immunology, 6(DEC). https://doi.org/10.3389/fimmu.2015.00633
Mendeley helps you to discover research relevant for your work.